Trials / Completed
CompletedNCT00883155
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets under Fasting Conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupropion HCl 100 mg Tablets (Invamed Inc.) | |
| DRUG | Wellbutrin 100 mg Tablets (Glaxo Wellcome) |
Timeline
- Start date
- 1998-10-01
- Primary completion
- 1998-10-01
- Completion
- 1998-10-01
- First posted
- 2009-04-17
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00883155. Inclusion in this directory is not an endorsement.